Rubius Therapeutics

About:

Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.

Website: http://www.rubiustx.com/

Twitter/X: rubius_tx

Top Investors: Flagship Pioneering

Description:

Rubius Therapeutics is creating RCTs™ as a new class of medicines. Leading applications include programs in cancer, enzyme deficiency diseases and the induction of tolerance to treat autoimmune disease. The company was conceived and launched by Flagship VentureLabs®, the innovation foundry where a team of scientific entrepreneurs systematically evolve enterprising ideas based upon previously undiscovered areas of science into real-world inventions and ventures.